Výsledky vyhledávání - "Tatjana Andrasiuk"

Akademický článek

ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer.

Autor: Lukasz A Kacprzyk, Mark Laible, Tatjana Andrasiuk, Jan C Brase, Stefan T Börno, Maria Fälth, Ruprecht Kuner, Hans Lehrach, Michal R Schweiger, Holger Sültmann

Publikováno v: PLoS ONE, Vol 8, Iss 3, p e59976 (2013)

Overexpression of ERG transcription factor due to genomic ERG-rearrangements defines a separate molecular subtype of prostate tumors. One of the consequences of ERG accumulation is modulation of the cell's gene expression profile. Tudor domain-contai

Externí odkaz: https://doaj.org/article/bc73dd54cbf64c3282e34c10879b0be8

Zobrazit plný text záznamu

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer

Autor: Mark Laible, Ruprecht Kuner, Stefan T. Börno, Maria Fälth, Holger Sültmann, Jan C. Brase, Tatjana Andrasiuk, Lukasz A. Kacprzyk, Hans Lehrach, Michal R. Schweiger

Publikováno v: PLoS ONE
PLoS One
PLoS ONE, Vol 8, Iss 3, p e59976 (2013)

Background Overexpression of ERG transcription factor due to genomic ERG-rearrangements defines a separate molecular subtype of prostate tumors. One of the consequences of ERG accumulation is modulation of the cell’s gene expression profile. Tudor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d6a62cc88318950ca6f992a86c0ed5
https://doi.org/10.1371/journal.pone.0059976

Zobrazit plný text záznamu

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling

Autor: Ruprecht Kuner, Stephan Gade, Tim Beißbarth, Guido Sauter, Michael Meister, Ronald Simon, Tatjana Andrasiuk, Marc Johannes, Lukasz A. Kacprzyk, Hüseyin Sirma, Maria Fälth, Ulrike Korf, Thorsten Schlomm, Holger Sültmann, Jan C. Brase, Heiko Mannsperger, Jennifer Metzger

Publikováno v: BMC Cancer, Vol 11, Iss 1, p 507 (2011)
BMC Cancer

Background TMPRSS2-ERG gene fusions occur in about 50% of all prostate cancer cases and represent promising markers for molecular subtyping. Although TMPRSS2-ERG fusion seems to be a critical event in prostate cancer, the precise functional role in c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea22705da4c992f5095f8ea398ec8995

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání